Post by c2crusher on Apr 10, 2018 13:04:08 GMT
This Form 8-K/A is being furnished to amend the Current Report on Form 8-K furnished by Cocrystal Pharma, Inc. (the “Company”) on
April 3, 2018. The sole purpose of the amendment is to update and clarify certain information in the investor presentation furnished as
Exhibit 99.1 to the original Form 8-K.
ir.cocrystalpharma.com/all-sec-filings/content/0001493152-18-004896/0001493152-18-004896.pdf
Cocrystal Influenza Program/Comparison with VX787
CC-42344 Exhibits Greater Affinity Than VX-787
Crusher
April 3, 2018. The sole purpose of the amendment is to update and clarify certain information in the investor presentation furnished as
Exhibit 99.1 to the original Form 8-K.
ir.cocrystalpharma.com/all-sec-filings/content/0001493152-18-004896/0001493152-18-004896.pdf
Cocrystal Influenza Program/Comparison with VX787
CC-42344 Exhibits Greater Affinity Than VX-787
Crusher